Answer
Yes, Rezolsta is contraindicated in patients with severe hepatic impairment (Child-Pugh Class C).
Sources for this answer
- REZOLSTA 800 mg/150 mg film coated tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 20Document updated
Sources checked